Targeting N-cadherin to Enhance Cytotoxicity of Melphalan in Regional Chemotherapy: Final Results of a Phase I Study of Systemic ADH-1 in Combination with Melphalan via Isolated Limb Infusion (M-ILI) in Patients (pts) with Locally Advanced In-transit Malignant Melanoma
Publication
, Conference
Beasley, GM; McMahon, N; Sanders, G; Augustine, CK; Zipfel, P; Padussis, J; Selim, MA; Petros, W; Peterson, B; Lawton, M; Norris, R; Ross, MI ...
Published in: ANNALS OF SURGICAL ONCOLOGY
February 1, 2009
Duke Scholars
Published In
ANNALS OF SURGICAL ONCOLOGY
ISSN
1068-9265
Publication Date
February 1, 2009
Volume
16
Start / End Page
2 / 3
Publisher
SPRINGER
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Beasley, G. M., McMahon, N., Sanders, G., Augustine, C. K., Zipfel, P., Padussis, J., … Tyler, D. S. (2009). Targeting N-cadherin to Enhance Cytotoxicity of Melphalan in Regional Chemotherapy: Final Results of a Phase I Study of Systemic ADH-1 in Combination with Melphalan via Isolated Limb Infusion (M-ILI) in Patients (pts) with Locally Advanced In-transit Malignant Melanoma. In ANNALS OF SURGICAL ONCOLOGY (Vol. 16, pp. 2–3). SPRINGER.
Beasley, G. M., N. McMahon, G. Sanders, C. K. Augustine, P. Zipfel, J. Padussis, M. A. Selim, et al. “Targeting N-cadherin to Enhance Cytotoxicity of Melphalan in Regional Chemotherapy: Final Results of a Phase I Study of Systemic ADH-1 in Combination with Melphalan via Isolated Limb Infusion (M-ILI) in Patients (pts) with Locally Advanced In-transit Malignant Melanoma.” In ANNALS OF SURGICAL ONCOLOGY, 16:2–3. SPRINGER, 2009.
Beasley GM, McMahon N, Sanders G, Augustine CK, Zipfel P, Padussis J, et al. Targeting N-cadherin to Enhance Cytotoxicity of Melphalan in Regional Chemotherapy: Final Results of a Phase I Study of Systemic ADH-1 in Combination with Melphalan via Isolated Limb Infusion (M-ILI) in Patients (pts) with Locally Advanced In-transit Malignant Melanoma. In: ANNALS OF SURGICAL ONCOLOGY. SPRINGER; 2009. p. 2–3.
Beasley, G. M., et al. “Targeting N-cadherin to Enhance Cytotoxicity of Melphalan in Regional Chemotherapy: Final Results of a Phase I Study of Systemic ADH-1 in Combination with Melphalan via Isolated Limb Infusion (M-ILI) in Patients (pts) with Locally Advanced In-transit Malignant Melanoma.” ANNALS OF SURGICAL ONCOLOGY, vol. 16, SPRINGER, 2009, pp. 2–3.
Beasley GM, McMahon N, Sanders G, Augustine CK, Zipfel P, Padussis J, Selim MA, Petros W, Peterson B, Lawton M, Norris R, Peters WP, Ross MI, Tyler DS. Targeting N-cadherin to Enhance Cytotoxicity of Melphalan in Regional Chemotherapy: Final Results of a Phase I Study of Systemic ADH-1 in Combination with Melphalan via Isolated Limb Infusion (M-ILI) in Patients (pts) with Locally Advanced In-transit Malignant Melanoma. ANNALS OF SURGICAL ONCOLOGY. SPRINGER; 2009. p. 2–3.
Published In
ANNALS OF SURGICAL ONCOLOGY
ISSN
1068-9265
Publication Date
February 1, 2009
Volume
16
Start / End Page
2 / 3
Publisher
SPRINGER
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis